Loading...

NEXTGEN LIQUICORE 12 GENE PANEL BY NGS, BLOOD

image not found

NABL Cap Accredited 
The NextGen LiquiCore 12 Gene Panel is a cutting-edge liquid biopsy test that analyzes 12 clinically relevant genes using blood samples. Metropolis Healthcare employs next-generation sequencing (NGS) to detect actionable mutations for cancer diagnosis, prognosis, and therapy selection. This minimally invasive panel supports personalized treatment planning, monitors disease progression, and guides targeted therapy decisions. It is particularly useful for patients unable to undergo tissue biopsy or those requiring real-time tumor profiling.

  • 17 Crores+ Samples Processed
  • World Class Technology Labs
  • 25+ Years of Trust & Experience
  • Free Home Collection

Price: Rs. 35,000.00

Sample Type: Peripheral Blood

Fasting Not Required


Booking Procedure:
  1. Technician from Metropolis will be assigned for a home sample collection after booking confirmation.
  2. Sample will be collected by our technician at your address at given slot.
  3. You can make the payment to the technician at the time of collection
  4. Your sample will then be transported to the nearest collection center and will be centrifuged before sending to the lab for processing.
  5. Soft copy reports will be sent to your email address within 24 to 48 hours or as per defined TAT for Tests.

Frequently Asked Questions (FAQ's):

What does the NextGen LiquiCore 12 Gene Panel test include?
It evaluates 12 key cancer-related genes for actionable mutations that inform diagnosis and treatment.

Who should take this test?
Patients with confirmed cancer, suspected malignancy, or those needing guidance for targeted therapy.

How is the sample collected?
A standard blood sample is collected for NGS-based liquid biopsy analysis.

Can this test guide personalized cancer therapy?
Yes, it identifies actionable mutations to help clinicians select targeted treatments and monitor response.

How does Metropolis Healthcare perform this test?
Metropolis Healthcare uses next-generation sequencing with stringent quality controls for accurate detection.

Is fasting required for the test?
No fasting is required.

Can this test monitor disease progression?
Yes, serial testing allows tracking of tumor mutations over time.

 

How long does it take to receive results from Metropolis Healthcare?
Results are generally available within 10–21 days, depending on the complexity of the analysis.

OUR corporates PARTNER

Feedback

Patient's Testimonials

Trusted by Thousands

OUR Accreditations

OUR Lab